臨床検査68巻5号

2024年05月発行

今月の特集 肥満と健康障害

内臓脂肪型肥満

著者： 武市幸奈¹³ 松田やよい¹ 小川佳宏²³

所属機関： ¹九州大学病院内分泌代謝・糖尿病内科（第三内科） ²九州大学大学院医学研究院病態制御内科学（第三内科） ³九州大学病院栄養管理部

ページ範囲：P.644 - P.651

Point

●肥満は体脂肪分布の違いから，内臓脂肪型肥満と皮下脂肪型肥満に大別される．

●脂肪組織の機能にはエネルギー調節とアディポサイトカインの産生・分泌がある．

●内臓脂肪の過剰な蓄積は，アディポサイトカイン産生異常やインスリン抵抗性を惹起し，糖尿病，脂質異常症や高血圧症ならびに心血管疾患を誘発する．

●日本人は白色人種と比較して，非肥満やごく軽度の肥満であっても内臓脂肪蓄積がみられ，糖尿病などの代謝異常や心血管疾患の合併リスクが高い．

●肥満を体格指数（BMI）のみで評価するのではなく内臓脂肪蓄積の観点から捉えたメタボリックシンドロームの概念は，わが国の肥満診療において大きな意味をもつ．

参考文献

1）World Obesity Federation (WOF)：World Obesity Atlas 2023（https://data.worldobesity.org/publications/?cat=19）（最終アクセス：2024年1月10日）

2）厚生労働省：令和元年国民健康・栄養調査（https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/kenkou_iryou/kenkou/eiyou/r1-houkoku_00002.html）（最終アクセス：2024年3月22日）

3）WHO Expert Consultation：Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet　363：157-163，2004

4）Caleyachetty R, Barber TM, Mohammed NI, et al：Ethnicity-specific BMI cutoffs for obesity based on type 2 diabetes risk in England: a population-based cohort study. Lancet Diabetes Endocrinol　9：419-426，2021

5）Okauchi Y, Nishizawa H, Funahashi T, et al：Reduction of visceral fat is associated with decrease in the number of metabolic risk factors in Japanese men. Diabetes Care　30：2392-2394，2007

6）Bouchi R, Minami I, Ohara N, et al：Impact of increased visceral adiposity with normal weight on the progression of arterial stiffness in Japanese patients with type 2 diabetes. BMJ Open Diabetes Res Care　3：e000081，2015

7）日本肥満学会（編）：肥満症診療ガイドライン2022，ライフサイエンス出版，2022

8）Tokunaga K, Matsuzawa Y, Ishikawa K, et al：A novel technique for the determination of body fat by computed tomography. Int J Obes　7：437-445，1983

9）Fujioka S, Matsuzawa Y, Tokunaga K, et al：Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism　36：54-59，1987

10）Hiuge-Shimizu A, Kishida K, Funahashi T, et al：Absolute value of visceral fat area measured on computed tomography scans and obesity-related cardiovascular risk factors in large-scale Japanese general population (the VACATION-J study). Ann Med　44：82-92，2012

11）Matsuzawa Y, Fujioka S, Tokunaga K, et al：A novel classification: visceral fat obesity and subcutaneous fat obesity. In: Recent Advances in Obesity Research, V (Berry EM, Blondheim SH, Eliahou HE, et al, eds), John Libbey, London, pp92-96，1987

12）Fujioka S, Matsuzawa Y, Tokunaga K, et al：Improvement of glucose and lipid metabolism associated with selective reduction of intra-abdominal visceral fat in premenopausal women with visceral fat obesity. Int J Obes　15：853-859，1991

13）Miyatake N, Nishikawa H, Morishita A, et al：Daily walking reduces visceral adipose tissue areas and improves insulin resistance in Japanese obese subjects. Diabetes Res Clin Pract　58：101-107，2002

14）Ross R, Neeland IJ, Yamashita S, et al：Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity. Nat Rev Endocrinol　16：177-189，2020

15）Ryo M, Kishida K, Nakamura T, et al：Clinical significance of visceral adiposity assessed by computed tomography: A Japanese perspective. World J Radiol　6：409-416，2014

16）Ryo M, Maeda K, Onda T, et al：A new simple method for the measurement of visceral fat accumulation by bioelectrical impedance. Diabetes Care　28：451-453，2005

17）Omura-Ohata Y, Son C, Makino H, et al：Efficacy of visceral fat estimation by dual bioelectrical impedance analysis in detecting cardiovascular risk factors in patients with type 2 diabetes. Cardiovasc Diabetol　18：137，2019

18）Ida M, Hirata M, Odori S, et al：Early changes of abdominal adiposity detected with weekly dual bioelectrical impedance analysis during calorie restriction. Obesity (Silver Spring)　21：E350-E353，2013

19）Shimomura I, Takahashi M, Tokunaga K, et al：Rapid enhancement of acyl-CoA synthetase, LPL, and GLUT-4 mRNAs in adipose tissue of VMH rats. Am J Physiol　270（6 Pt 1）：E995-E1002，1996

20）Kuriyama H, Yamashita S, Shimomura I, et al：Enhanced expression of hepatic acyl-coenzyme A synthetase and microsomal triglyceride transfer protein messenger RNAs in the obese and hypertriglyceridemic rat with visceral fat accumulation. Hepatology　27：557-562，1998

21）Choe SS, Huh JY, Hwang IJ, et al：Adipose Tissue Remodeling: Its Role in Energy Metabolism and Metabolic Disorders. Front Endocrinol (Lausanne)　7：30，2016

22）Kahn CR, Wang G, Lee KY：Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome. J Clin Invest　129：3990-4000，2019

23）Kita S, Maeda N, Shimomura I：Interorgan communication by exosomes, adipose tissue, and adiponectin in metabolic syndrome. J Clin Invest　129：4041-4049，2019

24）Stefan N, Häring HU, Hu FB, et al：Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol　1：152-162，2013

25）Tanabe H, Masuzaki H, Shimabukuro M：Novel strategies for glycaemic control and preventing diabetic complications applying the clustering-based classification of adult-onset diabetes mellitus: A perspective. Diabetes Res Clin Pract　180：109067，2021

26）Wang JS, Xia PF, Ma MN, et al：Trends in the Prevalence of Metabolically Healthy Obesity Among US Adults, 1999-2018. JAMA Netw Open　6：e232145，2023

27）Mongraw-Chaffin M, Foster MC, Anderson CAM, et al：Metabolically Healthy Obesity, Transition to Metabolic Syndrome, and Cardiovascular Risk. J Am Coll Cardiol　71：1857-1865，2018

28）Vishvanath L, Gupta RK：Contribution of adipogenesis to healthy adipose tissue expansion in obesity. J Clin Invest　129：4022-4031，2019

29）Tchkonia T, Thomou T, Zhu Y, et al：Mechanisms and metabolic implications of regional differences among fat depots. Cell Metab　17：644-656，2013

30）Miyachi Y, Tsuchiya K, Shiba K, et al：A reduced M1-like/M2-like ratio of macrophages in healthy adipose tissue expansion during SGLT2 inhibition. Sci Rep　8：16113，2018